Marina Johnson

Bio

Marina Johnson, MD, a UCLA/USC-trained physician is board-certified in Endocrinology and Internal Medicine. She is the Medical Director of The Institute of Endocrinology and Preventive Medicine in Irving, TX. Prior to medical school, she was a pharmacist and assistant editor for a drug reference book, AHFS-Drug Information.  Her medical practice focuses on women’s hormone health and cardiovascular prevention.  In her 30 years of medical practice, she has managed over 100,000 female patient visits.

 


Her book, Outliving Your Ovaries: An Endocrinologist Weighs The Risks And Rewards Of Treating Menopause With Hormone Replacement Therapy is supported by 450 medical journal articles and 30 years of clinical experience.  It’s a guidebook for women as they navigate the challenges of menopause. 


 


Dr. Johnson was an invited speaker at The Cleveland HeartLab Annual Symposium in September 2011, where she taught a new standard of care for menopause treatment. She has no financial ties to pharmaceutical companies.  Dr. Johnson is a quintessential clinician and patient advocate who seeks out the most effective, safest therapy for patients. She has been a featured guest on Lifetime Television, Daystar Television, and national radio, including NPR. She is a regular contributor to: EmpowHER, Beliefnet.com, ShareCare.com and Living Better at 50+. Dr. Johnson has been featured in many publications, including, Enterprising Women Magazine, The Dallas Morning News, The Boston Globe, The San Francisco Chronicle and Fox News.


 


For more information about Dr. Johnson visit www.DrMarinaJohnson.com


Please join us on Facebook at www.facebook.com/DrMarinaJohnson Follow Dr. Johnson on Twitter twitter.com/drmarinajohnson


 

Marina Johnson, M.D., F.A.C.E.
Medical Director
The Institute of Endocrinology and Preventive Medicine ®


 


 





Specialties:

Affiliation:

  • The Institute of Endocrinology and Preventive Medicine

Location:

Activity

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    MONDAY, June 17 (HealthDay News) -- People who eat a lot of red meat increase their risk of developing type 2 diabetes, while those who cut down on red meat cut their risk.

    Those are the findings of a large new study out of Singapore involving 149,000 U.S. men and women.

    The resea...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    MONDAY, June 10 (HealthDay News) -- Low blood sugar in older adults with type 2 diabetes may increase their risk of dementia, a new study suggests.

    While it's important for diabetics to control blood sugar levels, that control "shouldn't be so aggressive that you get hypoglycemia," said s...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    FRIDAY, June 7 (HealthDay News) -- Obese teens don't need to lose large amounts of weight to lower their risk of developing diabetes, according to a new study.

    Researchers found that obese teens who reduced their body-mass index (BMI) by 8 percent or more had improvements in insulin sensi...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    THURSDAY, June 6 (HealthDay News) -- The controversial diabetes drug Avandia will get a second look from federal regulators this week, nearly two years after its use was severely restricted because of a link to heart problems.

    The U.S. Food and Drug Administration has convened a panel of ...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    WEDNESDAY, June 5 (HealthDay News) -- Using an immune-suppressing medication and adult stem cells from healthy donors, researchers say they were able to cure type 1 diabetes in mice.

    "This is a whole new concept," said the study's senior author, Habib Zaghouani, a professor of microbiolo...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    SUNDAY, June 2 (HealthDay News) -- A drug already used for advanced kidney and liver cancers may help slow the progression of thyroid cancers that do not respond to standard treatment, a new clinical trial finds.

    Researchers found that the drug, called sorafenib (Nexavar), taken as a pill...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    TUESDAY, May 28 (HealthDay News) -- Researchers have developed a network of so-called "nanoparticles" that theoretically could be injected into the body and release insulin to counteract rising blood sugar levels in people with diabetes.

    Tested so far in mice, the nano-network was able to...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    THURSDAY, May 23 (HealthDay News) -- Certain statins -- the widely used cholesterol-lowering drugs -- may increase your chances of developing type 2 diabetes, a new study suggests.

    The risk was greatest for patients taking atorvastatin (brand name Lipitor), rosu...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    THURSDAY, May 23 (HealthDay News) -- Type 2 diabetes is more aggressive in children than adults, with signs of serious complications seen just a few years after diagnosis, new research finds.

    "Based on the latest results, it seems like type 2 is progressing more rapidly in children," sai...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    WEDNESDAY, May 22 (HealthDay News) -- People with heart failure are more likely to experience poorer health from having a thyroid gland that is even mildly underactive, according to a new study.

    And among black patients, the researchers found an increased risk of death linked to the cond...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    WEDNESDAY, May 22 (HealthDay News) -- Fish oil supplements could help reduce the risk for type 2 diabetes, new research suggests.

    The supplements, also known as omega-3 fatty acids, increase levels of a hormone called adiponectin that's linked to insulin sensitivity, Harvard researchers ...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    FRIDAY, May 10 (HealthDay News) -- For people with celiac disease, an accurate diagnosis and proper diet are essential for good health, experts say.

    Celiac disease is an intolerance to the protein gluten, which is found in wheat, barley and rye. When people with celiac disease eat gluten-...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    THURSDAY, April 25 (HealthDay News) -- A hormone that could lead to more effective diabetes treatment has been identified by researchers.

    The hormone, called betatrophin, causes mice to produce insulin-secreting pancreatic beta cells at up to 30 times the normal rate. But it only produces...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    THURSDAY, April 25 (HealthDay News) -- Drinking just one 12-ounce sugar-sweetened soft drink a day can increase the risk of developing type 2 diabetes by up to 22 percent, a European study contends.

    The finding is based on an analysis of data collected from more than 28,000 people in Denm...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    FRIDAY, April 12 (HealthDay News) -- Researchers have pinpointed a genetic mutation that is strongly associated with an increased risk of death in people with thyroid cancer.

    The investigators followed more than 1,800 patients after their initial treatment for papillary thyroid cancer, wh...Full Article